ARCH Venture Fund VII, L.P. - 30 Sep 2025 SCHEDULE 13G/A Report for UNITY BIOTECHNOLOGY, INC. Common Stock, par value $0.0001 per share (UNBX)

Filing Manager
ARCH Venture Fund VII, L.P.
Reporting Manager
ARCH Venture Fund VII, L.P.
Security
UNITY BIOTECHNOLOGY, INC. Common Stock, par value $0.0001 per share
Symbol
UNBX
Disclosed Ownership
0 shares
Ownership
0%
Form type
SCHEDULE 13G/A
Filing time
14 Nov 2025, 16:30:04 UTC
Date of event
30 Sep 2025
SEC
View on sec.gov

Reporting Managers (8)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
ARCH Venture Fund VII, L.P. 0% 0 0 0 /s/ ARCH Venture Partners VII, L.P. its General Partner
ARCH Venture Fund VIII Overage, L.P. 0% 0 0 0 ARCH Venture Partners VIII, LLC its General Partner
ARCH Venture Partners VII, L.P. 0% 0 0 0 /s/ ARCH Venture Parnters VII, LLC its General Partner
ARCH Venture Partners VII, LLC 0% 0 0 0 /s/ Mark McDonnell* Mark McDonnell, as Attorney-in-Fact for Keith Crandell, Managing Director
ARCH Venture Partners VIII, LLC 0% 0 0 0 /s/ Mark McDonnell* Mark McDonnell, as Attorney-in-Fact for Keith Crandell, Managing Director
Keith Crandell 0% 0 0 0 /s/ Mark McDonnell* Mark McDonnell, as Attorney-in-Fact for Keith Crandell
Clinton Bybee 0% 0 0 0 /s/ Mark McDonnell* Mark McDonnell, as Attorney-in-Fact for Clinton Bybee
Robert Nelsen 0% 0 0 0 /s/ Mark McDonnell* Mark McDonnell, as Attorney-in-Fact for Robert Nelsen